BioSpace News Archive

Policy

J&J Settles Stelara Issue with Teva, Alvotech

Following a May 2023 settlement with Amgen, J&J has also signed an agreement with Teva and Alvotech, allowing their Stelara biosimilar to enter the U.S. no later than February 21, 2025.

June 13, 2023
·
2 min read
·
Tristan Manalac
Business

Biogen Shareholders Elect Susan Langer to Board of Directors Despite Controversy

The company announced Monday its shareholders elected Susan Langer, current president of Souffle Therapeutics, to its board of directors, replacing her reputed romantic partner Alex Denner.

June 13, 2023
·
3 min read
·
Tristan Manalac
Biopharma Confronts a Rising Tide of Ransomware Attacks

The industry, seen as a lucrative target, has been victim of more and more cybersecurity breaches since the start of the COVID-19 pandemic.

June 13, 2023
·
4 min read
·
Shawna Williams
Drug Development

Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission

Data from a Phase II trial showed that Adcetris, used in a combination approach, is effective in early-stage classical Hodgkin lymphoma patients.

June 13, 2023
·
2 min read
·
Kate Goodwin
Drug Development

Turnstone Biologics Files for $86M IPO Amid Financial Difficulties

The initial public offering on the Nasdaq is a last-ditch effort by the biotech as there is “substantial doubt” as to the company’s “ability to continue as a going concern” without the IPO, according to its SEC filing.

June 13, 2023
·
2 min read
·
Connor Lynch
Drug Development

Valneva Reports Strong Phase III Chikungunya Vaccine Data After Merck’s Exit from Race

Valneva’s chikungunya vaccine candidate VLA1553 showed that the shot safely and rapidly induced high rates of seroprotection. Merck earlier in 2023 discontinued its chikungunya program.

June 13, 2023
·
2 min read
·
Tristan Manalac
A Chinese Neurosurgical Journal Study Presents Consensus on the Management of Aneurysmal Subarachnoid Hemorrhage-Related Hydrocephalus

Aneurysmal subarachnoid hemorrhage-related hydrocephalus is a clinical syndrome that leads to excessive accumulation of cerebrospinal fluid and ventricle enlargement in the brain.

June 13, 2023
·
3 min read
BioMidwest

New research from the Stowers Institute reveals the start of Huntington’s disease

Devastating neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s are all associated with protein deposits in the brain, known as amyloid.

June 13, 2023
·
5 min read
Pharm Country

Centinel Spine® Completes Enrollment in First-of-its-Kind 2-Level IDE Trial Evaluating prodisc® C Match-the-Disc™ Cervical TDR System

Centinel Spine®, LLC, (“the Company”) today announced the completion of enrollment in a first-of-its-kind Investigational Device Exemption (IDE) study evaluating the Company’s prodisc C Vivo and prodisc C SK cervical Total Disc Replacement (TDR) system.

June 13, 2023
·
4 min read
Lone Star Bio

QuVa Pharma Expands RFID Capabilities for Its Pre-Tagged, Ready-to-Administer Injectables

QuVa Pharma, Inc. announced that it is expanding its RFID embedded, pre-tagged product label platform to include RFID tags that adhere to GS1’s open, technology independent, global standards which enable interoperability and compatibility.

June 13, 2023
·
2 min read